[1]
Lebwohl, M., Warren, R.B. , Imafuku, S., Bagel, J. , Armstrong, A.W. , Passeron, T., Banerjee, S., Kisa, R.M., Vritzali, E. , Colombo, M.J., Scharnitz, T., Hoyt, K., Tha├ži, D. and Blauvelt, A. 2024. Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s365. DOI:https://doi.org/10.25251/skin.8.supp.365.